latent tuberculosis treatment evaluation & improvement tools – fishbone (cause/effect) diagram...

17
Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative Public Health Performance Management Centers for Excellence 1 Latent Tuberculosis Treatment Evaluation & Improvement 2014 Quality Improvement Grantees Learning Congress September 26, 2014 Clark County ---------------------------------------------- Derel Glashower, Epidemiologist Jeff Sogo, Public Health Nurse

Upload: vubao

Post on 30-May-2018

215 views

Category:

Documents


2 download

TRANSCRIPT

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

1

Latent Tuberculosis Treatment Evaluation & Improvement

2014 Quality Improvement GranteesLearning Congress

September 26, 2014

Clark County----------------------------------------------Derel Glashower, EpidemiologistJeff Sogo, Public Health Nurse

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Project Team

2

• Monica Czapla, Program Manager• Jeff Sogo, Public Health Nurse• Josh VanOtterloo, CSTE Epi Fellow• Alan Melnick, Health Director/Health Officer• Derel Glashower, Epidemiologist

Funded by the US Centers for Disease Control and Prevention

Public Health Performance ManagementCenters for Excellence

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

September 26, 2014

Clark County

3Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

• Total population: 442,800 (OFM)• ~47.5% in unincorporated areas

• Clark County Public Health (CCPH):– 78.15 FTEs – $10,131,149 annual budget (2013)– Currently working towards PH Accreditation

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

4

Problem Identified

0

5

10

15

20

25

2008 2009 2010 2011 2012

Num

ber

of L

TBI C

ases

Treatment Outcomes of LTBI Patients Managed by CCPH, 2008-2012

Complete

Incomplete

56%61%

70% 71%89%

0%

20%

40%

60%

80%

100%

2008 2009 2010 2011 2012

LTBI Treatment Completion Rates by YearCCPH 2008-2012

CDC LTBI2015Target

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

5

Background• Change in Department direction and

resources in 2008• Transferred nearly all clinical services,

including TB clinic, to community• Lost institutional knowledge of data

systems – TB Data!• Department staff reduced by 52.9 FTE• Continued to operate with efficiency

as high priority

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

6

Context1) New LTBI Treatment Regimen Available

• ~2012, 2 drugs for 3 months• Short course, excellent complement to eDOT

2) CCPH Changed Approach to LTBI Treatment• Prioritized and selectively treated LTBI patients

3) Culture Change on the CD Team• Grassroots effort by frontline staff to use eDOT

Risk Factor Reasonable* Estimate of Increased Risk

Documented Range of Risk Estimates

Tumor necrosis factor (TNF) inhibitor use 20+ 1.6 - 90.1HIV positive not on antivirals 10+ 4.1 - 24.0Malnourishment 10+ 2.2 - 37.5Children < 5 years of age 6 5.5 - 7.9Contacts to active cases/Recent Converters 3 1.7 - 3.4* Reasonable estimates are this analyst’s subjective estimate of increased risk based upon estimates in the scientific literature, study size and design, and CDC estimates

Funded by the US Centers for Disease Control and Prevention

Public Health Performance ManagementCenters for Excellence

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

September 26, 2014

AIM Statement

7

• To decrease the number of people who develop active Tuberculosis through the timely and efficient treatment of latent Tuberculosis infection (LTBI).

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

8

Project Activities• Assemble Team• Gathering the Data

• Identify Source• Abstract Information

• Identify Root Causes• Analyze Baseline Data

• Bar graphs with summary statistics• Explore Solutions

• Examine Costs and • Developed Solutions

• Implementation• New Process developed• Formalized processes

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Quality Tools – Fishbone (Cause/Effect) Diagram

9

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Quality Tools – Process Map

10

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Quality Tools – Improvement

11

Identify Potential Solutions:

• Provide patient-centered DOT experience- Recommended by CDC and WHO

• Encourage new 12-week regimen• Lend hardware, such as tablets, to

improve DOT adherence

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Quality Tools – Improvement

12

Develop an Improvement Theory:

IF we:• Provide an eDOT option• Encourage the 12-week regimen• Provide select clients with eDOT

hardwareTHEN:

• LTBI treatment completion rates will improve

• Costs for the department will decrease• Resources will be liberated for other

TB control objectives

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Results - Treatment Outcomes

13

56%61%

70% 71%89%

100% 100%

0%

20%

40%

60%

80%

100%

2008 2009 2010 2011 2012 2013 2014 YTD

LTBI Treatment Completion Rates by YearCCPH 2008-2014 YTD

CDC LTBI2015 Target

0

5

10

15

20

25

2008 2009 2010 2011 2012 2013 2014 YTD

Num

ber

of L

TBI C

ases

Year

Treatment Outcomes of LTBI Patients Managed by CCPH, 2008-2014 YTD

Incomplete

Complete

Public Health Performance Management Centers for ExcellenceSeptember 26, 2014

Results – Cost Savings

14

1700.34 1727.581666.19

1874.16

1670.62

1110.31

769.273

636.951

050

01,

000

1,50

02,

000

Aver

age

Cos

t ($)

2007 2008 2009 2010 2011 2012 2013 2014

CCPH 2008-2014YTDAverage Cost of LTBI Treatment Per Fully Treated Case

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

15

Next Steps• Consider expanding eDOT and LTBI treatment to other

lower-risk patients as resources permit• Create database for tracking all LTBI cases with QI

information that cannot be captured by other programs• Continue to improve data collection • Promote eDOT as a patient-centered approach that

improves treatment completion rates with inherent cost savings

• Robust Program assessment• Patient surveys• Analysis of missed doses, treatment interruption,

side-effects, cost, patient perception

Public Health Performance ManagementCenters for Excellence

Funded by CDC’s National Public Health Improvement Initiative September 24, 2014

For more information, contact:

Derel Glashower, [email protected]

Jeff Sogo, Public Health [email protected]

http://www.clark.wa.gov/public-health/

16

Public Health Performance Management Centers for Excellence

Funded by the U. S. Centers for Disease Control’s National Public Health Improvement Initiative

Public Health Performance Management Centers for Excellence

The contents of this presentation were selected by the author and do not necessarily represent the official position of or endorsement by the Centers for Disease Control and Prevention.